GR3003244T3 - Use of oligopeptids for the treatment of cerebral disorders - Google Patents

Use of oligopeptids for the treatment of cerebral disorders

Info

Publication number: GR3003244T3
Authority: GR; Greece
Prior art keywords: treatment; oligopeptids; cerebral disorders; tryptophan; cerebral
Prior art date: 1986-01-18

Application number

GR91401870T

Other languages

English (en)

Inventor

Klaus Sommermeyer

Burghard Weidler

Original Assignee

Fresenius Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-01-18

Filing date

1991-12-02

Publication date

1993-02-17

1991-12-02 Application filed by Fresenius Ag filed Critical Fresenius Ag

1993-02-17 Publication of GR3003244T3 publication Critical patent/GR3003244T3/el

Links

208000018152 Cerebral disease Diseases 0.000 title 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 abstract 2
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 abstract 2
AJHCSUXXECOXOY-NSHDSACASA-N Gly-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-NSHDSACASA-N 0.000 abstract 1
AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 abstract 1
108010038807 Oligopeptides Proteins 0.000 abstract 1
102000015636 Oligopeptides Human genes 0.000 abstract 1
208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract 1
230000002490 cerebral effect Effects 0.000 abstract 1
108010084389 glycyltryptophan Proteins 0.000 abstract 1
206010022437 insomnia Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

GR91401870T 1986-01-18 1991-12-02 Use of oligopeptids for the treatment of cerebral disorders GR3003244T3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19863601398 DE3601398A1 (de)	1986-01-18	1986-01-18	Verwendung von oligopeptiden zur behandlung von cerebralen stoerungen

Publications (1)

Publication Number	Publication Date
GR3003244T3 true GR3003244T3 (en)	1993-02-17

Family

ID=6292132

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GR91401870T GR3003244T3 (en)	1986-01-18	1991-12-02	Use of oligopeptids for the treatment of cerebral disorders

Country Status (7)

Country	Link
US (1)	US4849408A (el)
EP (1)	EP0234186B1 (el)
JP (1)	JPS62169730A (el)
AT (1)	ATE69163T1 (el)
DE (2)	DE3601398A1 (el)
ES (1)	ES2038603T3 (el)
GR (1)	GR3003244T3 (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3823464A1 (de) *	1988-07-11	1990-01-18	Asta Pharma Ag	Neue tryptophandipeptide
US5759991A (en) *	1990-03-29	1998-06-02	Sumitomo Pharmaceutical Company, Limited.	Neurotrophic peptide derivatives
US5354738A (en) *	1992-09-04	1994-10-11	G. D. Searle & Co.	Platelet aggregation inhibitors
US5438075A (en)	1993-03-30	1995-08-01	Skubitz; Keith M.	Oral glutamine to reduce stomatitis
CA2374003C (en) *	1999-05-17	2008-02-12	Aesgen, Inc.	Improved cellular uptake of bioactive agents
CA2493764C (en) *	2002-08-01	2011-05-24	Aesgen, Inc.	Improved treatment of cancer with glutamine
PT1953551E (pt) *	2002-12-03	2014-05-06	Pathogen Removal & Diagnostic Technologies Inc	Ligandos a proteína de prião e métodos de uso
RU2663691C2 (ru) *	2013-12-13	2018-08-08	Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова"	Фармацевтическая композиция амида n-(6-фенилгексаноил)глицил-l-триптофана с пленочным покрытием и способы ее получения
AU2018260628A1 (en) *	2017-04-25	2019-12-12	Temple Otorongo Llc	Pharmaceutical composition comprising tryptophan and phyllokinin derivative for use in treating psychiatric and psychological conditions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL175174C (nl) *	1972-03-31	1984-10-01	Akzo Nv	Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.
JPS51115909A (en) *	1975-04-01	1976-10-13	Otsuka Pharmaceut Factory Inc	A process for preparing amino acid parenteral injection mixed with a r educing sugar
US4110438A (en) *	1977-03-21	1978-08-29	American Home Products Corporation	Method of treating depression
US4405629A (en) *	1979-05-07	1983-09-20	Massachusetts Institute Of Technology	Process for increasing glycine levels in the brain and spinal cord
US4340592A (en) *	1980-03-14	1982-07-20	Adibi Siamak A	Nutrient compositions and method of administering the same
IT1148618B (it) *	1982-10-11	1986-12-03	Polifarma Spa	Procedimento enzimatico per la produzione di acido 3-indolpiruvico e utilizzazione farmaceutica di questo
GB8319174D0 (en) *	1983-07-15	1983-08-17	Erba Farmitalia	Biologically active heptapeptides
US4687763A (en) *	1985-02-25	1987-08-18	Massachusetts Institute Of Technology	Composition and method for increasing levels or release of brain serotonin
ES2061442T3 (es) *	1985-10-14	1994-12-16	Nippon Zoki Pharmaceutical Co	Peptidos.

1986
- 1986-01-18 DE DE19863601398 patent/DE3601398A1/de not_active Withdrawn
1987
- 1987-01-06 ES ES198787100072T patent/ES2038603T3/es not_active Expired - Lifetime
- 1987-01-06 EP EP87100072A patent/EP0234186B1/de not_active Expired - Lifetime
- 1987-01-06 AT AT87100072T patent/ATE69163T1/de not_active IP Right Cessation
- 1987-01-06 DE DE8787100072T patent/DE3774291D1/de not_active Expired - Lifetime
- 1987-01-07 US US07/001,517 patent/US4849408A/en not_active Expired - Fee Related
- 1987-01-13 JP JP62004217A patent/JPS62169730A/ja active Pending
1991
- 1991-12-02 GR GR91401870T patent/GR3003244T3/el unknown

Also Published As

Publication number	Publication date
EP0234186A1 (de)	1987-09-02
US4849408A (en)	1989-07-18
EP0234186B1 (de)	1991-11-06
ES2038603T3 (es)	1993-08-01
ATE69163T1 (de)	1991-11-15
JPS62169730A (ja)	1987-07-25
DE3774291D1 (de)	1991-12-12
DE3601398A1 (de)	1987-07-23

Similar Documents

Publication	Publication Date	Title
EP0441119A3 (en)	1992-10-14	The use of l-arginine in the treatment of hypertension and other vascular disorders
CS553490A3 (en)	1992-04-15	Transdermal therapeutic system
GB2207055B (en)	1990-12-19	Apparatus for use in the treatment of spinal disorders
HU9302384D0 (en)	1993-11-29	2,4-diamino-quinazoline derivatives and medical preparatives containing them
MY131298A (en)	2007-08-30	5-heteroyl indole derivatives
GR3006630T3 (el)	1993-06-30
Mullen	1986	Issues in the morphology and phonology of Amharic the lexical generation of pronominal clitics.
EP0326023A3 (en)	1990-09-05	Benzamide against cognitive disorders
GR3003244T3 (en)	1993-02-17	Use of oligopeptids for the treatment of cerebral disorders
NZ504419A (en)	2002-11-26	The use of carvedilol for treating amyloid diseases such as Alzheimer's
EP0275668A3 (en)	1989-10-11	Use of ketone derivatives in the treatment of cognitive disorders
AU1029588A (en)	1988-07-21	Synergistic combination of azelastine and theophylline or azelastine and beta-mimetics
ZA871062B (en)	1988-10-26	Use of aromatic diamines for the treatment of angina and diamines therefor
CA2068630A1 (en)	1992-11-15	Use of protein c or activated protein c
TW282455B (el)	1996-08-01
EP0450757A3 (en)	1993-09-15	Use of 5-hydroxytryptamine-antagonists in the treatment of mental disorders originating in childhood
ZA855224B (en)	1986-03-26	Pyrrol-1-ylphenyldihydropyridazinones,their preparation and their use
EP0350738A3 (de)	1991-04-03	(S)-Emopamil zur Anwendung bei der Behandlung von Migräne
ZA929390B (en)	1993-06-07	The use of D-fenfluramine and fenfluramine compounds in the treatment of hypertension in insulin-resistant subjects.
DK0519902T3 (el)	1997-02-17
AU1935988A (en)	1989-01-04	Electro-pneumatic device for massages and/or improving the venolymphatic circulation
ZA849576B (en)	1985-08-28	1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
DE68911509D1 (de)	1994-01-27	26-aminocholesterol und derivate und analoge davon bei der regulierung der cholesterolanhäufung in den körpergefässen.
GR3019819T3 (en)	1996-08-31	Use of wild garlic for the therapy or prevention of blood circulation disturbances.
NZ324615A (en)	2000-08-25	Method for treating autism using olanzapine